Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome.

[1]  B. Clarkson,et al.  Cyclical edema and shock due to increased capillary permeability. , 1960, Transactions of the Association of American Physicians.

[2]  T. Waldmann,et al.  SYSTEMIC CAPILLARY LEAK SYNDROME AND MONOCLONAL IgG GAMMOPATHY: Studies in a Sixth Patient and a Review of the Literature , 1977, Medicine.

[3]  R. Kyle,et al.  Control of systemic capillary leak syndrome with aminophylline and terbutaline. , 1992, The American journal of medicine.

[4]  J. Piette,et al.  Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. , 1997, The American journal of medicine.

[5]  P. Greipp,et al.  Treatment of the Systemic Capillary Leak Syndrome with Terbutaline and Theophylline: A Case Series , 1999 .

[6]  Terry M Therneau,et al.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.

[7]  T. Saeki,et al.  Systemic capillary leak syndrome. , 2002, Internal medicine.

[8]  A. Guermazi,et al.  Idiopathic Systemic Capillary Leak Syndrome: Cutaneous Involvement Can Be Misleading , 2004, Dermatology.

[9]  Rajiva Gupta,et al.  Idiopathic systemic capillary leak syndrome (SCLS): case report and systematic review of cases reported in the last 16 years. , 2007, Internal medicine.

[10]  E. Hachulla,et al.  High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome , 2008, Critical care medicine.

[11]  M. Gousseff,et al.  [Idiopathic capillary leak syndrome]. , 2009, La Revue de medecine interne.

[12]  C. Punt,et al.  Vascular endothelial growth factor in systemic capillary leak syndrome. , 2009, The American journal of medicine.

[13]  J. S. Lee,et al.  Beneficial effect of intravenous immunoglobulins on systemic capillary leak syndrome in patients with monoclonal gammopathy. , 2009, Critical care medicine.

[14]  S. Mandrekar,et al.  Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. , 2010, Mayo Clinic proceedings.

[15]  K. Druey,et al.  Narrative Review: The Systemic Capillary Leak Syndrome , 2010, Annals of Internal Medicine.

[16]  P. Abgueguen,et al.  Immunoglobulins for treatment of systemic capillary leak syndrome. , 2010, The American journal of medicine.

[17]  L. Arnaud,et al.  The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European Registry , 2011, Annals of Internal Medicine.

[18]  M. Zipponi,et al.  High-dose intravenous immunoglobulins: A promising therapeutic approach for idiopathic systemic capillary leak syndrome , 2011, BMJ Case Reports.

[19]  J. Cerhan,et al.  Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. , 2012, Mayo Clinic proceedings.

[20]  M. Rodríguez-Carballeira,et al.  Successful treatment of systemic capillary leak syndrome with intravenous immunoglobulins. , 2012, Revista clinica espanola.

[21]  Shoko Iwaki,et al.  Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). , 2012, Blood.

[22]  Zhihui Xie,et al.  Inflammatory Markers of the Systemic Capillary Leak Syndrome (Clarkson Disease) , 2014, Journal of clinical & cellular immunology.

[23]  M. A. D. O. Revuelto,et al.  Uso de inmunoglobulinas inespecíficas en un paciente con síndrome de fuga capilar , 2014 .

[24]  Zhihui Xie,et al.  High-dose intravenous immunoglobulin therapy for systemic capillary leak syndrome (Clarkson disease). , 2015, The American journal of medicine.

[25]  L. Duron,et al.  [Idiopathic and secondary capillary leak syndromes: A systematic review of the literature]. , 2015, La Revue de medecine interne.

[26]  E. Hachulla,et al.  Subcutaneous Immunoglobulin Therapy Prevents Systemic Capillary Leak Syndrome Attack. , 2016, The American journal of medicine.